Garen Bohlin

Insider Reports History

Entity
Individual
Location
C/O Praecis Pharmaceuticals Inc, 830 Winter Street, Waltham, MA
Signature
/s/ Nancy Smith, Attorney-in-Fact for Garen Bohlin
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Garen Bohlin:

Stock Role Class Num Shares Value Price $ Report Date Ownership
COLLEGIUM PHARMACEUTICAL, INC Director Common Stock 52.5K $1.69M $32.30 May 16, 2024 Direct
Karyopharm Therapeutics Inc. Director Common Stock 45.1K $37K $0.82 Sep 12, 2023 Direct
Karyopharm Therapeutics Inc. Director Nonstatutory Stock Option (right to buy) 69K May 29, 2024 Direct
COLLEGIUM PHARMACEUTICAL, INC Director Stock Option (Right to Purchase) 0 May 14, 2024 Direct

Insider Reports Filed by Garen Bohlin

Symbol Company Period Transactions Value $ Form Type Date Filed Role
KPTI Karyopharm Therapeutics Inc. May 29, 2024 1 $0 4 May 30, 2024 Director
COLL COLLEGIUM PHARMACEUTICAL, INC May 14, 2024 4 -$770K 4 May 16, 2024 Director
KPTI Karyopharm Therapeutics Inc. Sep 12, 2023 1 $50K 4 Sep 12, 2023 Director
KPTI Karyopharm Therapeutics Inc. May 24, 2023 1 $0 4 May 25, 2023 Director
COLL COLLEGIUM PHARMACEUTICAL, INC May 18, 2023 1 $0 4 May 19, 2023 Director
COLL COLLEGIUM PHARMACEUTICAL, INC May 19, 2022 1 $0 4 May 23, 2022 Director
KPTI Karyopharm Therapeutics Inc. May 19, 2022 1 $0 4 May 20, 2022 Director
KPTI Karyopharm Therapeutics Inc. May 21, 2021 1 $0 4 May 21, 2021 Director
COLL COLLEGIUM PHARMACEUTICAL, INC May 20, 2021 1 $0 4 May 24, 2021 Director
KPTI Karyopharm Therapeutics Inc. May 6, 2021 1 $31.3K 4 May 10, 2021 Director